SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells by Voronkova, Maria A et al.
Faculty Scholarship 
2017 
SOX9 Regulates Cancer Stem-Like Properties and Metastatic 
Potential of Single-Walled Carbon Nanotube-Exposed Cells 
Maria A. Voronkova 
Sudjit Luanpitpong 
Liying W. Rojanasakul 
Vincent Castranova 
Cerasela Z. Dinu 
See next page for additional authors 
Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications 
Authors 
Maria A. Voronkova, Sudjit Luanpitpong, Liying W. Rojanasakul, Vincent Castranova, Cerasela Z. Dinu, 
Heimo Riedel, and Yon Rojanasakul 
1Scientific RepoRts | 7: 11653  | DOI:10.1038/s41598-017-12037-8
www.nature.com/scientificreports
SOX9 Regulates Cancer Stem-Like 
Properties and Metastatic Potential 
of Single-Walled Carbon Nanotube-
Exposed Cells
Maria A. Voronkova1, Sudjit Luanpitpong  2,5, Liying Wang Rojanasakul6, Vincent 
Castranova2, Cerasela Zoica Dinu3, Heimo Riedel1,4 & Yon Rojanasakul1,2
Engineered nanomaterials hold great promise for the future development of innovative products 
but their adverse health effects are a major concern. Recent studies have indicated that certain 
nanomaterials, including carbon nanotubes (CNTs), may be carcinogenic. However, the underlying 
mechanisms behind their potential malignant properties remain unclear. In this study, we linked SOX9, 
a stem cell associated transcription factor, to the neoplastic-like properties of human lung epithelial 
cells chronically exposed to a low-dose of single-walled carbon nanotubes (SWCNTs). We found 
that SOX9 is upregulated in SWCNT-exposed cells, which is consistent with their abilities to induce 
tumor formation and metastasis in vivo. We therefore hypothesized that SOX9 overexpression may 
be responsible for the neoplastic-like phenotype observed in our model. Indeed, SOX9 knockdown 
inhibited anchorage-independent cell growth in vitro and lung colonization in vivo in a mouse xenograft 
model. SOX9 depletion also suppressed the formation of cancer stem-like cells (CSCs), as determined by 
tumor sphere formation and aldehyde dehydrogenase (ALDH) activity (Aldefluor) assays. Furthermore, 
SOX9 knockdown suppressed tumor metastasis and the expression of the stem cell marker ALDH1A1. 
Taken together, our findings provide a mechanistic insight into SWCNT-induced carcinogenesis and the 
role of SOX9 in CSC regulation and metastasis.
Engineered nanomaterials have increasingly been used for various applications, but their long-term health effects 
are largely unknown. Carbon nanotubes (CNTs) are one of the most commonly used engineered nanomaterials 
due to their unique properties such as light weight, high tensile strength, and electrical conductivity1, 2. However, 
CNTs have some negative properties as well, such as a high aspect ratio and biopersistence; therefore, questions 
about their potential carcinogenicity have been raised3, 4. Previous animal studies have shown that pulmonary 
exposure to single-walled carbon nanotubes (SWCNTs) induces inflammation, granulomas, and fibrosis5, 6, condi-
tions that have been associated with an increased risk of lung cancer7, 8. In fact, some CNTs can induce or promote 
tumor formation in animals3, 9–12. Furthermore, one type of CNTs, multi-walled carbon nanotubes (MWCNTs) 
Mitsui-7, was classified as possibly carcinogenic to humans by the International Agency for Research on Cancer 
(IARC)13, while in vitro data on other CNT types were concluded insufficient to be extrapolated to humans.
We previously reported that long-term, low-dose exposure of human lung epithelial cells to SWCNTs and 
MWCNTs results in neoplastic-like transformation14, 15. Long-term treatment with CNTs was applied to mimic 
gradual cellular transformation during cancer development, a process that may require a prolonged exposure 
to carcinogens16–18. We also reported that chronically SWCNT-exposed cells contain a highly invasive and 
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tumorigenic stem-like cell subpopulation19, 20. However, detailed information about the underlying mechanisms 
remains unknown.
Increasing amounts of evidence suggest that cancer stem cells or stem-like cells (CSCs), also called tumor ini-
tiating cells, are the main driving force behind tumor formation and metastasis21, 22. CSCs and regular stem cells 
share many properties, including self-renewal capacity, potency for differentiation, and resistance to apoptosis. 
More importantly, CSCs are typically resistant to chemotherapy and eventually give rise to recurrent tumors22, 23.
Many stem cell regulatory proteins are now being recognized as oncogenes because of their ability to regulate 
CSCs. SOX9 (SRY (sex determining region Y)-box 9) is a member of the SOX family of transcription factors, 
which play critical roles in embryonic development, lineage commitment, and stem cell maintenance24. Notably, 
SOX9 is involved in lung branching morphogenesis25, and its expression is elevated in many types of cancer, 
including lung, skin, brain, and pancreatic cancers26. In non-small cell lung cancer (NSCLC), the most common 
type of lung cancer, SOX9 expression highly correlates with the disease progression and poor patient survival27, 28. 
Accumulating evidence also suggests that SOX9 may regulate CSCs29–32. However, detailed mechanisms have yet 
to be elucidated. Furthermore, it is not known whether SOX9 plays a role in SWCNT-induced carcinogenesis and 
CSC formation.
In this study, we demonstrated that chronically SWCNT-exposed human lung cells display high levels of 
SOX9 expression and contain a distinct CSC subpopulation. We hypothesized that SOX9 overexpression may be 
responsible for the malignant phenotype observed in these cells. Consequently, we evaluated the effects of SOX9 
expression on the tumorigenicity, invasiveness, and stemness of SWCNT-transformed cells in vitro and in vivo.
Results
Exposure to carbon nanotubes induces cell transformation. To test the potential role of SOX9 in 
SWCNT-induced oncogenesis, human bronchial epithelial Beas-2B cells were continuously exposed to occupa-
tionally relevant concentrations (0.02 μg/cm2) of SWCNTs for a period of 6 months, as previously described14, 15, 19. 
Physicochemical properties of SWCNTs used in this study are summarized in Table 1. Potential carcinogenic 
properties and SOX9 expression were then evaluated in vitro and in vivo. Analysis of anchorage-independent 
cell growth, a hallmark of cancer33, 34, revealed that the SWCNT-treated cells (termed BSW) formed 5-fold more 
colonies when compared to passage-matched control (B2B) cells (Fig. 1a). To evaluate the tumorigenic potential 
of BSW cells in vivo, these cells and the control B2B cells were genetically labeled with luciferase and injected 
subcutaneously into the flanks of NOD/SCID gamma mice. Tumor formation was examined over a period of 4 
weeks by external caliper measurements and by bioluminescence imaging. Unlike control cells, BSW cells formed 
rapidly growing tumors (Fig. 1b,c). Moreover, ex vivo analysis at the end of the experiments showed spontaneous 
metastasis of the BSW cells to the mouse lungs and liver (Fig. 1d,e,f and Supplementary Fig. S1). These results 
indicate that SWCNT-transformed cells possess tumorigenic and metastatic properties.
SOX9 overexpression regulates malignant properties of BSW cells. Cancer stem cells (CSCs) 
are considered to be the main source of cancer metastasis, chemoresistance, and tumor recurrence21. Previous 
studies have shown that SWCNT-exposed cells contain a CSC-like subpopulation identical to CSCs reported in 
lung cancer19, 35. This cell population is characterized by the expression of stem cell markers, self-renewal abil-
ity, and more importantly by chemoresistance and high tumorigenic potential19, 20. In this study, we examined 
the molecular mechanisms of CSC regulation to identify possible biomarkers and drug targets for CNT-related 
malignancies. SOX9, a stem cell transcription factor, has recently been implicated in CSC regulation26, 29 and is 
overexpressed in non-small cell lung cancer (NSCLC)27, 32. We hypothesized that SOX9 may regulate the tum-
origenic and metastatic properties of SWCNT-exposed cells by controlling CSCs. Indeed, BSW cells express a 
high level of SOX9 protein when compared to passage-matched control cells (Fig. 2a). Furthermore, immunos-
taining analysis revealed that lungs of all mice in the BSW group contain SOX9 overexpressing micrometastases 
(Fig. 2b). Immunofluorescent staining for CSC markers in control and SWCNT-exposed cells demonstrated that 
CSC markers are overexpressed in BSW cells and that the CSCs are the cells that have elevated SOX9 expression 
(Supplementary Fig. S2).
To test our hypothesis, SOX9 expression in BSW cells was stably knocked down by shRNAs (Fig. 3a). The 
knockdown cells (shSOX9) exhibited a slower rate of proliferation (Fig. 3b) and formed substantially fewer col-
onies in the soft agar assay when compared to vector control cells (Fig. 3c,d). These results suggest that SOX9 
depletion alleviates the survival of cells in matrix depleted conditions and potentially decreases their metastatic 
potential. In vitro migration and invasion assays further demonstrated a marked reduction in cell motility fol-
lowing SOX9 knockdown (Fig. 4). We also used an established NSCLC cell line H460 to compare the results 
Characteristic Value Method used for characterization
% carbon (w/w) 99% Nitric acid dissolution, inductive coupled plasma-
atomic emission spectrometry (ICP-AES, NMAM 
#7300)
% Fe (w/w) 0.23%
Other metals Not detectable
Surface area 400–1000 m2/g
Nitrogen absorption-desorption technique (Brunauer 
Emmet Teller method, BET) using SA3100 Surface 
Area and Pore Size Analyzer (Beckman Coulter)
Dry length, µm 0.1–1
Field emission scanning electron microscopy
Dry width, nm 0.8–1.2
Table 1. Physicochemical properties of SWCNTs used in this study.
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of SOX9 downregulation in BSW cells to those in lung cancer cells. SOX9 knockdown also attenuated colony 
formation and decreased the proliferation rate of H460 cells (Supplementary Fig. S3), which is consistent with 
previous reports28, 32. Taken together, our results support the critical role of SOX9 overexpression in the malignant 
phenotype of SWCNT-exposed cells. Specifically, SOX9 knockdown reduced cell proliferation, colony formation, 
migration, and invasion - properties that all are considered as hallmarks of cancer33.
SOX9 regulates SWCNT-induced cancer stem cells. The ability for self-renewal is a key characteristic 
of stem cells36, 37. The tumor sphere formation assay has frequently been used as a functional in vitro test to evalu-
ate the self-renewal ability of adult stem cells and cancer stem cells38, 39. To evaluate the sphere forming capability 
of SWCNT-transformed cells and its regulation by SOX9, 1,000 control and shSOX9 cells were cultured under 
non-adherent conditions in serum-free medium. After 2 weeks in culture, the number of tumor spheres exceed-
ing 50 µm in diameter was quantified. We found that SOX9 knockdown substantially inhibited sphere formation 
(Fig. 5a), suggesting that SOX9 positively regulates stem cells in our model.
Figure 1. Human bronchial epithelial cells, chronically exposed to carbon nanotubes, undergo malignant 
transformation. (a) Chronically SWCNT-exposed bronchial epithelial Beas-2B (BSW) cells were cultured in soft 
agar for 2 weeks, and colonies over 50 μm in diameter were counted, n = 15, p < 0.0001, two-tailed t-test. Scale 
bar = 500 μm. (b) Luciferase-labeled cells were injected subcutaneously into flanks of NOD/SCID gamma mice 
(n = 5 per group), and tumor volume was measured weekly by an external caliper. Means are different according 
to Bonferroni post hoc analysis following 2-way ANOVA, p < 0.05. (c) Weight of isolated subcutaneous tumors 
at week 4, p = 0.0014, two-tailed t-test. (d) Top – representative bioluminescent signal from tumors at week 
4, Bottom – representative luciferase signal from isolated internal organs. (e) Luciferase signal from lungs 
imaged ex vivo. (f) Representative images of H&E stained lungs from mice bearing BSW cells. Arrows point to 
metastatic modules. Scale bar, 50 µm. Data are mean ± SEM.
www.nature.com/scientificreports/
4Scientific RepoRts | 7: 11653  | DOI:10.1038/s41598-017-12037-8
Figure 2. Human bronchial epithelial cells, chronically exposed to carbon nanotubes, overexpress SOX9. (a) 
Immunoblot of BSW and control cells, showing significant SOX9 overexpression in BSW cells. Right – relative 
SOX9 expression presented as fold change over control cells (n = 6). Data are mean ± SEM, *p = 0.0347, paired 
two-tailed t-test. (b) Representative image of lung metastases from mice bearing BSW cells subcutaneously; 
sections were stained with anti-SOX9 antibody and antibody against human mitochondria, nuclei stained with 
DAPI. Scale bar: 20 µm.
Figure 3. SOX9 knockdown inhibits proliferative and colony-forming properties of BSW cells. (a) Immunoblot 
showing levels of SOX9 protein after knockdown generated by 3 different shRNAs (sh-1, sh-2, sh-3), empty 
vector was used as a control in BSW cells. (b) Rate of cell proliferation, p < 0.05, Bonferroni post hoc analysis 
following 2-way ANOVA. (c) Soft agar colony formation assay. Cells were cultured in soft agar for 2 weeks, scale 
bar −500 μm. (d) Quantification of the soft agar assay, colonies larger than 50 μm in diameter were counted, 
n = 3. Data presented as mean values ± SEM. Means are different according to Turkey post hoc analysis 
following ANOVA, p < 0.05.
www.nature.com/scientificreports/
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Next, we evaluated the expression and activity of the common cancer stem marker ALDH, which is highly 
active in cancer stem cells and is frequently associated with poor clinical outcomes23, 40, 41. The Aldefluor assay 
was used to quantify ALDH activity in BSW and BSW-shSOX9 cells. The activated Aldefluor reagent is a 
cell-permeable fluorescent substrate for ALDH that accumulates inside cells after interaction with ALDH and can 
be subsequently detected using flow cytometry. Diethylaminobenzaldehyde (DEAB), a specific ALDH inhibitor, 
was used to evaluate background fluorescence and set up gates for flow cytometry. We found that ALDH activ-
ity was substantially decreased in SOX9 knockdown cells, as indicated by a reduced number of cells exhibiting 
high ALDH activity (ALDHhi cells) (Fig. 5b,c). Consistent with the pattern of ALDH activity, expression levels 
of ALDH1A1, one of the main CSC-associated ALDH isoforms42, 43, were dramatically reduced following SOX9 
knockdown (Fig. 5d). ALDH1A1 expression was also depleted in H460-shSOX9 cells (Supplementary Fig. S3), 
indicating that a correlation between SOX9 and ALDH expression is not limited to one specific cell system. These 
results suggest that SOX9 controls CSCs in BSW cells and possibly other cancer cell types through ALDH1A1.
SOX9 knockdown attenuates BSW metastasis in vivo. We next evaluated whether SOX9 depletion 
affects the metastatic potential of BSW cells in vivo. Luciferase-labeled BSW and BSW-shSOX9 cells were intrave-
nously injected into mice followed by weekly bioluminescence imaging. At the end of the experiment, mice were 
euthanized; their internal organs (brain, liver, spleen, pancreas, kidneys and lungs) were removed and imaged to 
evaluate metastatic lesions. Figure 6a shows representative whole-body bioluminescence images of mice bearing 
either the control or shSOX9 cells. Importantly, lung colonization by shSOX9 cells was dramatically decreased 
when compared to control cells (Fig. 6b). This was also confirmed by ex vivo lung imaging (Fig. 6c) and by his-
tological analysis (Fig. 6d). The luminescent signal from distant metastases in the liver and brain also decreased 
(Fig. 6e,f). In addition, we observed an occasional luciferase signal from the kidneys and pancreas in the control 
but not in the shSOX9 animals (data not shown). Our findings indicate a significant role of SOX9 in the regulation 
of the metastatic properties of malignantly transformed BSW cells.
SOX9 overexpression in normal Beas-2B cells induces stem cell-like properties. We next over-
expressed SOX9 in passage-matched control (B2B) cells to test whether this would be sufficient to recapitulate 
the phenotype of BSW cells. Of note, we achieved a maximum 5-fold increase of SOX9 expression (Fig. 7a), 
while BSW cells have on average a 15-fold increase in SOX9 expression in comparison to Beas-2B cells (Fig. 2a). 
Nevertheless, a 5-fold SOX9 overexpression in Beas-2B cells was sufficient to promote tumor sphere formation 
Figure 4. SOX9 knockdown attenuates migration and invasion of BSW cells in vitro. SOX9 knockdown was 
generated by 3 different shRNAs (sh-1, sh-2, sh-3), empty vector used as a control in BSW cells. BSW cells were 
added to control inserts (migration) or inserts coated with Matrigel (invasion) and incubated for 15 h. After 
removal of non-migrated and non-invaded cells, cells were fixed and stained with crystal violet and counted 
under a microscope. (a) Transwell migration assay. Bottom – quantification. (b) Transwell invasion assay. 
Bottom - quantification. Data presented as mean ± SEM, n = 10. Means are different according to Turkey post 
hoc analysis following ANOVA, p < 0.05.
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 11653  | DOI:10.1038/s41598-017-12037-8
Figure 5. SOX9 regulates cancer stem cells in SWCNT-exposed cells. SOX9 knockdown was generated by 3 
different shRNAs (sh-1, sh-2, sh-3), empty vector used as a control in BSW cells. (a) Tumor sphere formation 
assay. Right – quantitative analysis of tumor sphere formation, n = 15. (b) Fold change in the number of ALDHhi 
cells in SOX9 knockdown over control BSW cells, 4 independent experiments combined (n = 4–9) measured 
by Aldefluor assay. (c) Representative flow cytometry results for Aldefluor assay. Top row – cells stained with 
the Aldefluor substrate only, bottom – cells stained with the Aldefluor substrate in the presence of the specific 
ALDH inhibitor DEAB. (d) SOX9 knockdown leads to a depletion of cancer stem cell marker ALDH1A1, 
right – quantification of relative ALDH1A1 expression, fold changes over control BSW cells, n = 3 independent 
experiments. Results are mean ± SEM. Means are different according to Turkey post hoc analysis following 
ANOVA, p < 0.05. DEAB - N,N-diethylaminobenzaldehyde.
www.nature.com/scientificreports/
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Figure 6. SOX9 knockdown inhibits BSW metastasis in vivo. Luciferase-labeled cells were injected 
intravenously via tail vein into NOD/SCID gamma mice (n = 4 per group) and mice were imaged right after 
cell injection and weekly thereafter. SOX9 knockdown was generated by 3 different shRNAs (sh-1, sh-2, 
sh-3), empty vector used as a control in BSW cells. (a) Representative whole body bioluminescence of lung 
tumors in mice injected with control vector (BSW) or SOX9 knockdown (shSOX9-3). (b) Time course of lung 
tumor growth generated by weekly whole body imaging, each time point normalized to the signal from day 
0. Means are different according to Bonferroni post hoc analysis following 2-way ANOVA, p < 0.05. (c,e,f) Ex 
vivo luciferase signal from isolated mouse lungs, brain and liver, respectively. Means are different according 
to Turkey post hoc analysis following ANOVA. (d) Representative pictures of H&E stained lungs showing a 
notable decrease in tumor lung colonization by SOX9 knockdown cells comparing to control cells, scale bar 
−250 µm. Data are shown as mean ± SEM, n = 4.
www.nature.com/scientificreports/
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(Fig. 7b,c). Note that these cells normally form a small number of loose cell aggregates under low-attachment 
conditions, while SOX9 overexpression triggered the appearance of typical, round tumor spheres. Furthermore, 
mRNA levels of main NSCLC-associated isoforms ALDH1A1 and ALDH1A344 as well as ALDH activity were 
upregulated by SOX9 (Fig. 7d,e). We also evaluated changes in the expression levels of stem cell related proteins 
in response to SOX9 overexpression. We observed an increased expression of CD133, a marker of lung CSCs45, 
and embryonic stem cell factors Nanog, SOX2 and Oct4, although the increase was not statistically significant in 
the case of Oct4 (Fig. 7f). Together, these results support the regulatory role of SOX9 in lung CSCs induction and 
ALDH1A1 expression.
Figure 7. SOX9 overexpression in Beas-2B cells induces stem cell-like properties. (a) Level of SOX9 
overexpression. (b) Representative images of tumor sphere formation. Scale bar, 200 µm. (c) Quantitative analysis 
of tumor sphere formation form (b), n = 3, p = 0.0019, two-tailed unpaired t-test. (d) RT-qPCR analysis of 2 
ALDH isoforms, n = 6–12, 2 independent experiments combined, p < 0.05 by two-tailed unpaired t-test. (e) Fold 
change in the number of ALDHhi cells in SOX9 overexpressing cells over control measured by Aldefluor assay, 
combined results from 4 independent experiments (n = 17), p = 0.004, two-tailed paired t-test. (f) Expression 
levels of stem cell markers were examined by RT-qPCR, n = 6–9, p < 0.05 according to Bonferroni post hoc 
analysis following 2-way ANOVA, GFP control vs SOX9 overexpression. n.s. - not significant. Data are shown as 
mean ± SEM.
www.nature.com/scientificreports/
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Discussion
In this study, we demonstrated that lung epithelial cells chronically exposed to SWCNTs may undergo malig-
nant transformation and gain metastatic properties. These cells displayed traits typically characteristic of cancer 
cells, including anchorage-independent growth and in vivo tumor formation, supporting the previously published 
work14, 19. In addition, the metastatic potential of SWCNT-exposed cells was demonstrated for the first time. We 
observed that BSW cells can metastasize in both subcutaneous (Fig. 1) and tail vein mouse models (Fig. 6). We 
showed for the first time that SOX9 is a critical player in SWCNT-induced carcinogenesis, and that SOX9 deple-
tion significantly reduces metastatic potential both in vitro (Fig. 4) and in vivo (Fig. 6).
Cancer stem cells (CSCs) have been considered the main source of cancer initiation, dissemination, and recur-
rence based on their ability for self-renewal, drug- and apoptosis resistance. Furthermore, multiple studies have 
illustrated that tumor initiating cells share some characteristics with regular stem cells and express stem cell 
markers. Thus, it is not surprising that many proteins that are involved in embryonic development, such as the 
SOX family of proteins, appear to be CSC drivers. Our study demonstrated a high level of SOX9 expression 
in aggressive SWCNT-exposed cells, consistent with recent reports of SOX9 up-regulation in multiple cancer 
types26. However, the functional role of SOX9 in transformed cells required further investigation. We hypothe-
sized that the elevated SOX9 expression in cancer cells and SWCNT-exposed cells may induce CSC formation, 
which in turn could drive tumor formation and metastasis. Indeed, we found that SOX9 knockdown strongly 
inhibited tumor sphere formation and anchorage-independent growth (Figs 5a and 3c,d). Bioluminescence sig-
nals from mouse lungs in the tail vein model clearly demonstrated that SOX9 knockdown decreases lung col-
onization (Fig. 6). Together, these results suggest that SOX9 regulates cancer cell survival, consistent with our 
previous work in lung cancer32.
We tested how SOX9 affects CSC markers to further evaluate our hypothesis. Elevated activity of ALDH, an 
enzyme with a variety of functions including detoxification, is associated with poor clinical outcomes due to 
metastasis and has been linked to CSCs23, 40, 41. We observed a substantial decrease in ALDH activity following 
SOX9 knockdown (Fig. 5d,c), suggesting that ALDH may be a potential downstream target of SOX9. Likewise, 
the expression of ALDH1A1, an ALDH isoform most commonly associated with the CSC activity23, 40, 42, was 
dramatically reduced in both BSW and H460 knockdown cells (Fig. 5d, Supplementary Fig. S3). Notably, ALDH 
serves not only as a stem cell marker, but also governs stem cell differentiation46, 47 by producing retinoic acid48. To 
further explore the potential relationship between ALDH and SOX9, we overexpressed SOX9 in control Beas-2B 
cells. We observed an increase in tumor sphere formation (Fig. 7b,c), which is consistent with the knockdown 
experiments. Likewise, mRNA levels of the reported to be overexpressed in NSCLC ALDH isoforms ALDH1A1 
and ALDH1A344 were elevated, validating our findings in SOX9 knockdown cells. We also observed an increased 
expression of stem cell makers CD133, Nanog and SOX2 (Fig. 7f), suggesting that SOX9 overexpression renders 
cells less differentiated. Collectively, our observations strongly support the positive regulatory role of SOX9 in 
CSC formation, consistent with other studies in pancreatic, esophageal, and colorectal cancers30, 49, 50. To our 
knowledge, the present study demonstrates the link between SOX9 and ALDH expression for the first time. This 
provides a key mechanism underlying CSC induction by SOX9, while the exact mode of ALDH upregulation 
remains a subject for further investigation.
A limitation of this study is that the results were largely derived from one cell model (Beas-2B cells) and one 
type of CNTs. However, our group observed a similar neoplastic-like transformation in several other models and 
with different types of CNTs. For examples, MWCNTs have recently been shown to induce neoplastic transfor-
mation of primary human small airway epithelial cells51. Both SWCNTs and MWCNTs similarly induced such 
transformation in hTERT-immortalized human small airway epithelial cells after a long-term exposure15. The 
induction of fibroblast stem-like cells and ALDH1A1 expression was also reported in primary human lung fibro-
blasts exposed to SWCNTs or MWCNTs51. Furthermore, co-culture of these activated fibroblasts with lung cancer 
cells promoted CSC-related properties and tumor formation by cancer cells52. Of note, animal experiments in the 
current study were conducted in immunodeficient mice, and therefore these results should be interpreted with 
caution. Nonetheless, several other studies using immunocompetent mice and rats consistently indicate the tum-
origenic potential of SWCNTs and MWCNTs9–12. While SOX9 is implicated as a key regulator of SWCNT-induced 
carcinogenesis in this report, other regulatory mechanisms are likely to be involved due to the complexity of 
carcinogenic process. For example, Shvedova et al. showed that inhalation or aspiration of SWCNTs caused lung 
inflammation and fibrosis along with K-ras mutation in immunocompetent mice53. Since K-ras is a known onco-
gene, whose mutational activation is frequently associated with an increased risk of lung cancer, it is quite possible 
that such mutation may be involved in SWCNT-induced carcinogenesis, although this has not been demon-
strated yet. In addition, several studies evaluating CNT carcinogenicity via whole transcriptome arrays have iden-
tified cancer signatures and known cancer prognostic markers in exposed mouse lung tissues54, 55. Some of the 
identified genes such as caveolin-1 and Bcl-2 have already been implicated in CNT-induced carcinogenesis20, 56  
and may be responsible for the early neoplastic transformation induced by SWCNTs.
Lung cancer is a progressive disease commonly associated with a long-term exposure to carcinogens. 
However, prolonged exposure studies to nanomaterials are lacking and are greatly needed for risk assessment and 
for safe-by-design strategies. Our results suggest that long-term exposure to SWCNTs could transform normal 
epithelial cells into metastatic tumor cells. Although multiple mechanisms and signaling pathways are likely to 
be involved in the transformation process, we report here the critical role of SOX9 in the transformation through 
CSC-related mechanisms. Given that CSCs may be involved in cancer initiation steps, we suggest that SOX9 
may be used as an early biomarker for SWCNT-induced carcinogenesis. It remains to be elucidated whether 
SOX9 up-regulation and its contribution to malignancies are specific to SWCNTs or could be extrapolated to 
other CNTs. Such information will aid in the design of nanomaterial-specific biomarkers for risk assessment and 
safe-by-design efforts.
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Methods
Cell culture and exposure to SWCNTs. Immortalized human bronchial epithelial Beas-2B cells were 
obtained from the American Type Culture Collection (ATCC). Cells were cultured in advanced Dulbecco’s 
modified Eagle medium (DMEM) (Life Technologies) supplemented with 1% fetal bovine serum (FBS, Atlanta 
Biologicals), 2 mM L-glutamine, 20 mM HEPES, 100 units/mL penicillin and 100 μg/mL streptomycin in 5% CO2 
at 37 °C. This cell model has been reported to be an appropriate model for in vitro lung carcinogenesis studies57. 
The cells were exposed to well-characterized single-walled CNTs (SWCNTs), as previously described14, 19. Briefly, 
SWCNTs (Carbon Nanotechnology (CNI)) were purified by acid treatment to remove metal contaminates. 
Particle characterization studies were performed at NIOSH research facilities, and the results are summarized 
in Table 1. Particles were treated with acetone and placed in an ultrasonic bath at room temperature for 24 h. 
The dispersed CNTs were then filtered from the solution using a 20 μm nylon mesh screen followed by a 0.2 μm 
polytetrafluoroethylene (PTFE) filter. After filter collection, the dispersed CNTs were washed thoroughly with 
distilled water to remove acetone. The filter was dried overnight in vacuum and weighed to determine the quan-
tity of SWCNTs. The particles were suspended in phosphate-buffered saline (PBS) by brief sonication and added 
to the cells every 3–4 days when changing the culture medium. Subconfluent cultures of Beas-2B cells were con-
tinuously exposed to a low-dose, occupationally relevant concentration (0.02 μg/cm2 or 0.1 μg/mL) of SWCNTs 
in culture for 6 months and passaged weekly. Cells were rinsed with PBS prior to culture medium changes and cell 
passaging to reduce potential SWCNT bioaccumulation over the exposure period.
The dose of SWCNTs used in this study was calculated based on reported effects of in vivo MWCNT exposure, 
normalized to mouse alveolar surface area. The lowest dose, which induced a biological response in vivo, was 10 μg/
mouse lung (0.5 mg/kg body weight)6. Dividing this dose by the average mouse alveolar surface area (~500 cm2) 
gives the in vitro surface area dose of 0.02 μg/cm2, which is roughly equivalent to a human lung burden for 8 hours/
day over a month at 400 μg/m3 (high CNT level reported in a research facility)58 or about 3 years at 10 μg/m3 (aver-
age CNT level in U.S. facilities)59. The cells were cultured in normal medium without SWCNTs for at least ten pas-
sages prior to further experiments Control cells were cultured for the same period of time in the above described 
culture medium. H460 (NCI-H460) cells were purchased from the ATCC and were passaged less than 20 times. 
H460 cells were maintained in RPMI medium (Corning) supplemented with 10% FBS, 100 units/mL penicillin, 
and 100 μg/mL streptomycin.
Plasmids and generation of stable cell lines. pLKO.1 lentiviral plasmids for SOX9 knockdown gen-
eration were purchased from GE Healthcare (#RHS4533-EG6662). An empty vector was used as a control, and 
the virus was produced in HEK293T cells (ATCC). Briefly, HEK293T cells were co-transfected with the shRNA 
containing pLKO.1 plasmids or empty pLKO.1 vector, pCMV-VSV-G envelope, and psPAX2 packaging plasmids 
(Addgene #8454, 12260) in the presence of FuGene 6 transfection reagent (Promega). The medium containing 
viral particles was collected at 24, 36, and 48 hours post-transfection, pooled, and used to infect SWCNT-exposed 
(BSW) cells in the presence of hexadimethrine bromide (Sigma-Aldrich) at a final concentration of 5 μg/mL. 
After infection, cells were selected with 1 μg/mL of puromycin (Life Technologies). For SOX9 overexpression, 
SOX9 cDNA from pCMV-AC-GFP-SOX9 (Origene) was amplified by PCR introducing BamHI/SalI restriction 
sites and was subcloned into pLenti CMV GFP Zeo (Addgene #17449), replacing GFP. pLenti CMV GFP Zeo 
vector was used as a control. For flow cytometry experiments (Aldefluor assay), control vector with RFP instead 
of GFP was used. Viral particles were produced as described above.
Immunoblotting. Cells were lysed in a non-reducing loading buffer containing 63 mM Tris-HCl pH 6.8, 
10% glycerol, and 2% sodium dodecyl sulfate (SDS). Protein concentrations were quantified using the Pierce BCA 
protein assay kit (Thermo-Scientific). Proteins (40 μg) were resolved under denaturing conditions by 7.5–12% 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membranes (EMD Millipore). 
Membranes were blocked in 5% non-fat milk in TBS-T buffer (25 mM Tris-HCl, pH 7.4, 125 mM NaCl, and 0.1% 
Tween 20) for 1 hour, washed 3 times for 5 minutes with TBS-T buffer, and incubated with appropriate primary 
antibodies at 4 °C overnight. Membranes were rinsed 3 times for 5 minutes with TBST-T buffer; membranes 
were then incubated with appropriate HRP-conjugated secondary antibodies (Jackson Immunoresearch), diluted 
in TBS-T for 1 hour at room temperature. Immune complexes were detected by enhanced chemiluminescence 
(Pierce ECL, Thermo-Scientific; Immobilon HRP Substrate, Millipore) and quantified with the Image Studio Lite 
program (Li-COR Biosciences). Antibodies used in this study are listed in the Supplementary Table 1. Full length 
unprocessed blot images are provided in the Supplementary Materials.
Flow cytometry. The ALDHhi population (cells with high aldehyde dehydrogenase activity) was identified 
by staining cells with the Aldefluor kit (Stem Cell Technologies), according to the manufacturer’s instructions. 
Briefly, for each sample, 3 × 105 cells were incubated in the Aldefluor assay buffer with the activated Aldefluor 
substrate for 45 minutes at 37 °C in the presence or absence of the specific ALDH inhibitor diethylaminoben-
zaldehyde (DEAB). Tubes stained with both the Aldefluor substrate and DEAB served as a negative control for 
each sample. ALDH converts Aldefluor substrate into a fluorescent product, and cells with high ALDH activity 
(ALDHhi) were detected by BD Fortessa cell analyzer (BD Biosciences). The flow cytometry gates were set to 
obtain 0.1% ALDHhi cells in substrate + inhibitor tubes for each sample. All experiments were performed at least 
3 times.
Soft agar colony formation assay. Cells were suspended in a soft agar medium containing 0.33% Difco 
agar (BD Biosciences) in 2x EMEM medium (Lonza) supplemented with L-glutamine, antibiotics and 15% FBS, 
and plated onto 6-well plates over a layer of 0.5% soft agar medium. Cells were cultured under standard cell cul-
ture conditions and were fed with 0.2 mL of the regular medium twice a week. Plates were observed under a light 
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microscope after 2 weeks, and colonies exceeding 50 μm in diameter were scored. Experiments were performed 
in triplicates; at least 5 fields of view for each replicate were evaluated.
Migration and invasion assays. Cells were seeded in the upper chamber of Transwell matrigel coated 
(invasion) or control inserts (migration) with 8 µm pores (Corning) in serum-free medium and were allowed to 
migrate or invade toward the serum-containing bottom chamber for 15 hours. Cells were subsequently removed 
from the top part of the chamber using a cotton swab, and cells on the bottom side were stained with crystal vio-
let. Experiments were performed in at least duplicates, 5 random fields were photographed under a light micro-
scope for each replicate.
Cell proliferation assay. The rate of cell proliferation was measured by seeding equal numbers of cells onto 
6-well plates in duplicates and counting cells with the Countess automated cell counter (Life Technologies) every 
2 days until plates become confluent.
Tumor sphere formation assay. Cells were plated onto ultra-low attachment 24-well plates (Corning) in 
0.8% methylcellulose (MC)-based serum-free medium (Stem Cell Technologies, #H4100) supplemented with 
20 ng/mL epidermal growth factor (BD Biosciences), 10 ng/mL basic fibroblast growth factor (Sigma-Aldrich), 
and 5 mg/mL insulin (Sigma-Aldrich). The number of tumor spheres exceeding 50 µm in diameter (20 µm for 
Beas-2B cells) was quantified under a light microscope after 2 weeks of culture under standard cell culture con-
ditions. All experiments were performed in triplicates and repeated at least twice, with 5 fields of view analyzed 
for each replicate.
Mouse xenograft experiments. All experiments were performed in accordance with the Guidelines 
for Animal Experiments at West Virginia University and approved by the Institutional Animal Care and Use 
Committee. Immunodeficient NOD/SCID gamma mice (NSG), strain NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (Jackson 
Laboratory), were injected with 1 × 106 of luciferase-labeled cells subcutaneously or via the tail vein. Tumor 
growth was monitored weekly using IVIS Lumina II in Vivo Imaging system (PerkinElmer), and an external cali-
per (VWR International) was used for the subcutaneous model. Tumor volume was calculated using the formula: 
tumor volume [mm3] = 1/2 (length [mm]) × (width [mm]2). At the end of the experiments mice were euthanized, 
and their organs were removed and imaged ex vivo on a Petri dish to evaluate metastasis. Bioluminescent images 
were quantified using the Living Image software (PerkinElmer). Tissue processing and H&E staining was carried 
out by the WVU Pathology Laboratory for Translational Medicine using standard procedures.
Immunohistochemistry. Tissue sections were deparaffinized using standard techniques. Antigen retrieval 
was carried out by heating slides in a microwave in citrate buffer (10 mM citric acid, 0.05% Tween 20, pH 6.0) 
for 30 min. Samples were blocked for 30 min with normal goat serum (BioGenex, #HK112–9K) and incu-
bated with primary antibodies overnight at 4 °C (specific antibodies used are listed in Supplementary Table 1). 
Slides were rinsed with TBS-T buffer 3 times and incubated with fluorescently labeled secondary antibodies 
(Life Technologies) for 1 hour at room temperature; after which they were rinsed with TBS-T buffer 3 times and 
mounted with the ProLong DAPI (Life Technologies). Cells were visualized with a Zeiss fluorescent microscope 
(Carl Zeiss).
Immunofluorescence. Cells were grown overnight on 8-well chamber slides (Nunc), fixed with 4% para-
formaldehyde and permeabilized with 100% methanol at −20 °C prior to blocking with 5% BSA in PBS. Cell were 
incubated with specific primary antibodies (listed in Supplementary Table 1), rinsed with PBS and incubated 
with secondary antibodies. Secondary antibodies were goat-anti-rabbit Alexa Fluor 546 (Life Technologies) and 
donkey-anti-mouse Alexa Fluor 488 (Jackson Immunoresearch). Slides were mounted with Fluoroshield with 
DAPI (Abcam) and visualized with a Zeiss fluorescent microscope (Carl Zeiss).
RT-qPCR. Total RNA was purified using the RNeasy kit (Qiagen). Reverse transcription was performed with 
SuperScript III Reverse Transcriptase (Life Technologies) using oligo(dT) primers. Quantitative real-time PCR 
was carried out using the SYBR Green Master Mix (Applied Biosystems) in an ABI 7500 Real-Time PCR Cycler 
(Applied Biosystems). Results were calculated using the 2−ΔΔCt method; glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) served as the internal control. Primer sequences are listed in the Supplementary Table 2.
Statistical analysis. The data represent means ± SEM from two or more independent experiments as indi-
cated. Statistical comparisons were made using two-tailed Student’s t test. When more than two groups were 
analyzed, ANOVA was used. Statistical analysis was performed with GraphPad Prism software (GraphPad), and 
p < 0.05 was considered statistically significant.
Data Availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
Disclaimer. The findings and conclusions in this report are those of the authors and do not necessarily repre-
sent the views of the National Institute for Occupational Safety and Health.
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